Alzheimer's Disease is one of the most pressing unmet clinical needs and is a huge cost to healthcare systems and societies. Recent developments in Alzheimer's diagnostics are nothing short of revolutionary and promise to unlock improved patient outcomes and valuable new markets. Join Amati managers Mikhail Zverev and Graeme Bencke as they discuss how they pursue this opportunity in the WS Amati Global Innovation Fund.